Last updated: July 17, 2026

Application No. 18/605,320

Compositions of Azadirachta Indica and Methods of Treating Cancer

Non-Final OA

Filed

Mar 14, 2024

Priority

Aug 31, 2018 — provisional 62/725,484 +3 more

Examiner

ROMERO, KRISTEN WANG

Art Unit

1624

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Board of Regents of the University of Texas System

OA Round

1 (Non-Final)

Interview Optional

— +29.4% interview lift. Examiner has a relatively high allowance rate (71%); +29.4% interview lift. A written response may suffice.

Based on 35 resolved cases, 2023–2026

Examiner Intelligence

ROMERO, KRISTEN WANG View full profile →

Grants 71% — above average

Career Allowance Rate

25 granted / 35 resolved

+11.4% vs TC avg

Strong +29% interview lift

Without

With

+29.4%

Interview Lift

resolved cases with interview

Typical timeline

3y 2m

Avg Prosecution

29 currently pending

Career history

Total Applications

across all art units

Statute-Specific Performance

§101

1.5%

-38.5% vs TC avg

§103

18.8%

-21.2% vs TC avg

§102

8.3%

-31.7% vs TC avg

§112

39.9%

-0.1% vs TC avg

Black line = Tech Center average estimate • Based on career data from 35 resolved cases

Prosecution Timeline

Mar 14, 2024

Application Filed

Apr 21, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/018,805

Patent 12673052

COMBINATIONS FOR THE TREATMENT OF CANCER

3y 5m to grant Granted Jul 07, 2026

18/267,691

Patent 12653802

METHOD FOR TREATING LUNG CANCER

3y 0m to grant Granted Jun 16, 2026

17/627,590

Patent 12649732

POLYMORPHS OF (R)-N-(5-(5-ISOPROPYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-METHYL-2H-TETRAZOLE-5-CARBOXAMIDE

4y 4m to grant Granted Jun 09, 2026

18/087,881

Patent 12630505

Alkyne Compound, Vitamin D Compound, Analytical Method, and Production Method

3y 4m to grant Granted May 19, 2026

17/720,192

Patent 12622974

SIDEROPHORE-DIHYDROFOLATE REDUCTASE INHIBITOR CONJUGATE AND APPLICATION THEREOF

4y 1m to grant Granted May 12, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

71%

Grant Probability

99%

With Interview (+29.4%)

3y 2m (~10m remaining)

Median Time to Grant

Low

PTA Risk

Based on 35 resolved cases by this examiner. Grant probability derived from career allowance rate.